NextFin

Kroger Cuts Sales Forecast as Pharmacy Drag Bites; Oracle Rallies on AI Cloud Boom

Summarized by NextFin AI
  • Kroger cut its fiscal 2026 same-store sales guidance to 0.2%-0.8% from 1.0%-2.0% after Q2 identical sales excluding fuel grew just 0.2%, sending shares down 2.6% to $55.48.
  • Kroger reaffirmed adjusted EPS guidance of $5.10-$5.30 despite the sales cut, supported by cost control, a $1.0 billion buyback, an 11% dividend raise, and leverage at 1.91x EBITDA.
  • Oracle's cloud infrastructure revenue surged 121% to $7.4 billion, with remaining performance obligations climbing to $664 billion and fiscal 2027 revenue guided to at least $90 billion.
  • Oracle spent $28.5 billion on capex, pushing free cash flow to negative $5 billion, while raising $20 billion in equity to fund its AI infrastructure buildout amid valuation debate.

NextFin News - Two of the week's most-watched earnings reports sent Wall Street in opposite directions on Thursday and Friday: Kroger cut its full-year same-store sales outlook after identical sales excluding fuel grew just 0.2% in the second quarter, while Oracle's stock rebounded after it posted 121% growth in cloud infrastructure revenue and guided fiscal 2027 revenue to at least $90 billion. The split is a clean read on the two regimes defining the late-2026 market - a consumer business absorbing a policy-driven revenue hit, and an AI infrastructure buildout that is still accelerating even as it burns cash.

The Numbers That Moved the Tape

Kroger reported second-quarter fiscal 2026 results before the bell on Friday, Sept. 11, for the 13 weeks ended Aug. 15. Sales rose to $34.6 billion from $33.9 billion a year earlier, and adjusted earnings per share came in at $1.09, up 5% from $1.04 - a one-cent beat over the $1.05 consensus compiled ahead of the print. But the figure that drove the stock was the guidance cut. The grocer now expects identical sales excluding fuel to grow only 0.2% to 0.8% for fiscal 2026, down from the 1.0% to 2.0% range it set on June 18. Shares fell 2.6% to $55.48 before the open.

Oracle, reporting after the close on Thursday, Sept. 10, told a different story. Non-GAAP earnings per share rose 30% to $1.92, beating the $1.74 estimate, on total revenue of $19.3 billion, up 30% and ahead of the roughly $19.13 billion forecast. Cloud infrastructure revenue more than doubled to $7.4 billion, up 121%, and remaining performance obligations - a backlog measure - climbed $209 billion year over year to $664 billion. The stock, which had closed the regular session down 5.38% at $152.94 on 56.82 million shares, rebounded in after-hours trading and was changing hands around $163.46 in premarket Friday, up 6.88%.

The divergence is not just about two tickers. It is about which promise investors are willing to pay for: Kroger promises cash flow you can count on, and Oracle promises growth you have to believe in.

Why Kroger's Profit Guidance Survived a Sales Cut

The first question any investor asks after a sales downgrade is whether profits are next. Kroger's answer was no: it reaffirmed adjusted EPS guidance of $5.10 to $5.30, FIFO operating profit of $5.0 billion to $5.2 billion, free cash flow of $2.7 billion to $2.9 billion, capital spending of $3.8 billion to $4.0 billion, and a 23% tax rate. The mechanism behind that resilience sits in the margin bridge.

Gross margin slipped to 22.4% of sales from 22.5%, but the FIFO gross margin rate excluding rent, depreciation, amortization and fuel actually improved 13 basis points. Operating profit rose to $971 million from $863 million, even as adjusted FIFO operating profit edged down to $1,076 million from $1,091 million. In plain terms, the company is making slightly less on each basket but controlling costs and mix well enough to hold the profit line. The $39 million LIFO charge for the quarter - a bookkeeping adjustment that rises when inventory costs climb - did not derail the quarter.

There is also a financial-engineering component. Kroger repurchased $1.0 billion of its own stock in the quarter and $1.2 billion year to date, with about $800 million left under its $2 billion authorization. Fewer shares mean the same dollar profit produces a higher per-share result. That is not organic growth, but it is a lever management can pull when top-line momentum stalls. The dividend increase - 11%, the 20th consecutive annual raise - reinforces the cash-flow story, and leverage at a net total debt to adjusted EBITDA ratio of 1.91 remains comfortably below the company's own 2.30 to 2.50 target range. Kroger is not in distress. It is in a low-growth, cash-generating phase.

Where the growth actually came from in the quarter matters for what comes next. Adjusted eCommerce sales grew 20%, and profit at Kroger Precision Marketing - the company's retail-media advertising arm - rose 24%. Those are higher-margin businesses than running supermarkets, but they remain small relative to $34.6 billion in quarterly sales. They are the seed of a margin story, not yet the trunk.

The Pharmacy Drag Is Structural, Not Cyclical

The crux of the cyclical-versus-structural call for Kroger is the roughly 140 basis point drag the company attributed to the Inflation Reduction Act. The law reduced what Medicare beneficiaries pay for prescription drugs, which reduced the revenue Kroger books on those prescriptions. That is not a temporary demand shock that mean-reverts when consumer sentiment improves. It is a repricing of a regulated revenue stream, written into law, and it compounds through the fiscal year.

This distinction matters because it changes how to read the sales cut. A cyclical slowdown - shoppers trading down, skipping discretionary aisles, delaying big trips - would show up across the basket and would likely fade as wages and confidence recover. The IRA impact shows up in one category: pharmacy. Prescription drugs are not a discretionary line item customers can defer, so the volume of scripts keeps flowing even as the dollars booked per script fall. Kroger still earns its dispensing margin; it just collects less revenue per prescription filled. That is why the top-line downgrade did not force a profit downgrade.

The second-order risk is what happens to the rest of the store. If pharmacy traffic or basket attachment erodes because customers start to see the pharmacy as less central to their shopping trip, the margin cushion that protected this quarter's profit guidance thins. That is the channel to watch, not the headline identical-sales number alone. Same-store sales excluding fuel were +3.4% a year earlier; the swing to +0.2% is almost entirely explained by the policy change. Strip out the IRA effect and the underlying trend is closer to flat-to-modest growth, which is a very different story from a consumer rolling over.

The company's own timeline underscores the structural reading. Management said it would lay out additional strategic initiatives and longer-term financial targets at an investor update meeting on Oct. 20, 2026. When a company defers the growth narrative to a special session rather than the earnings call, it is usually because the answer requires explaining a multi-year repositioning, not a one-quarter fix.

Oracle's Growth Is Real - the Question Is What the Market Pays for It

Oracle's numbers are not easy to dismiss. Cloud infrastructure revenue growing 121% to $7.4 billion in a single quarter, on a base that was already large, is a rate of scale rarely seen outside the earliest years of a new technology cycle. Total cloud revenue rose 62% to $11.6 billion, while cloud applications grew 10% to $4.2 billion.

Customer demand for AI Cloud Training and Inferencing Services continues to grow faster than supply.

The company said in its first-quarter fiscal 2027 earnings release that it booked more than $30 billion of additional AI cloud contracts in the quarter, lifting remaining performance obligations to $664 billion. Since the end of the fourth quarter, it delivered more than 300,000 GPUs to AI cloud customers and almost tripled the capacity delivered in Q4 fiscal 2026, adding 850 megawatts of datacenter capacity in Q1 alone.

Remaining performance obligations of $664 billion - up $209 billion year over year - give Oracle revenue visibility that most of the S&P 500 would envy. Management's guide of at least $90 billion in fiscal 2027 revenue, non-GAAP EPS of $8.10, and 65% to 71% cloud revenue growth in the current quarter tells investors the acceleration is not peaking. Total revenue is expected to grow 30% to 34% in the current quarter.

But the bill for that growth is equally large, and it is the heart of the valuation debate. Oracle spent $28.5 billion on capital expenditure in the quarter, pushing free cash flow to negative $5 billion, even as operating cash flow hit a record $23 billion, up 184%. That is the structural nature of the AI infrastructure race: you must build datacenters before the revenue arrives, and the winner is the company that builds fastest, not the one that preserves this quarter's cash flow. To fund the program, Oracle completed the sale of $20 billion of common stock through an at-the-market equity program during the quarter, and said the structuring of the new AI contracts leaves its capital-raising plans unchanged.

The stock's behavior around the print shows how divided investors are. Heading into the report, shares were down roughly 18% year to date and about 34% over the past year, after the roughly 36% single-day surge that followed the prior September's earnings. The regular-session 5.38% drop on Sept. 10 was a bet against the sustainability of the AI capex story; the after-hours and premarket reversal was a bet that the $664 billion backlog justifies it. The setup is a classic expectation gap: the business is executing, but the shares had already been marked down on financing fears.

The Counter-Thesis: Capex Discipline and Consumer Resilience

The strongest case against reading these two reports as a clean divergence is simpler than either story. For Oracle, the bear argument is that a $28.5 billion quarterly capex bill is not sustainable if AI demand normalizes, and that negative free cash flow will eventually force either slower growth or shareholder dilution. The $20 billion equity raise is evidence that the market is already being asked to fund the buildout. If cloud infrastructure growth decelerates below the 65% lower bound of management's current-quarter guide, the entire valuation built on perpetual hypergrowth cracks - because the capacity would sit idle while the financing costs keep accruing.

For Kroger, the bull counter-argument is that the consumer is more resilient than the guidance suggests. Same-store sales excluding fuel remain positive, grocery is defensive, the IRA drag is fully disclosed and now priced into the new range, and the stock does not carry a growth multiple. A grocer in this position does not need expansion; it needs stability, and Kroger still has it - profit guidance intact, leverage below target, a rising dividend, and a buyback still running.

Both counter-theses are testable, which is what makes them useful. The falsifying signal for the divergence trade is specific: if Oracle's cloud infrastructure growth falls below 65% in the current quarter while free cash flow remains deeply negative, the AI-buildout narrative loses its momentum premium. Conversely, if Kroger's identical sales excluding fuel return above 1.0% next quarter without the IRA drag worsening, the sales cut will look like a conservative reset rather than a structural break. One number from each company, next quarter, decides which regime was mispriced.

What Comes Next: Scenarios by Time Horizon

In the short term, Kroger's shares are likely to stay under pressure until the Oct. 20 investor update, when management is scheduled to present longer-term targets. The reaction will depend less on the quarter - which the market has now digested - and more on whether the company can show a credible path back to 1%-plus identical sales growth. For Oracle, the near-term path runs through converting $664 billion of backlog into revenue without blowing through capex guidance, and through the market's read of the $20 billion equity raise as either prudent pre-funding or a warning sign.

Over the medium term, the split between the two stocks could narrow. If AI capex moderates, Oracle's multiple compresses even as earnings grow - a painful combination for a momentum-held name. If the IRA pharmacy headwind proves more persistent than expected and grocery traffic weakens, Kroger's profit guidance becomes harder to defend, and the market will ask whether the buyback can keep masking a shrinking top line.

The base case is that Kroger lands in the middle of its $5.10 to $5.30 EPS range with flat-to-low single-digit sales growth, and that Oracle grows cloud infrastructure at 60% to 80% through fiscal 2027 while free cash flow stays negative but funded. The upside case for Kroger is a consumer that keeps spending and a pharmacy book that stabilizes; the upside case for Oracle is AI demand that exceeds even the $90 billion guide. The downside for Kroger is a deeper identical-sales decline that forces an earnings cut; the downside for Oracle is a growth deceleration that forces a capex cut.

Longer term, the question is which business model compounds. The regulated, buyback-supported staple can deliver steady returns in a low-growth world, but it rarely re-rates. The capital-intensive infrastructure platform can re-rate dramatically if today's capacity becomes tomorrow's cash machine - but only if demand keeps arriving faster than supply. The market is not choosing between right and wrong this week. It is choosing between two different kinds of risk: the risk of stagnation, and the risk of belief.

The takeaway is sharper than the headlines suggest. Kroger's cut is a revenue repricing, not a profit crisis - and the market punished it anyway. Oracle's burn is a financing choice, not a demand problem - and the market rewarded it anyway. In a late-cycle market, that inversion is the point: investors are paying for the story they need, not the quarter they got.

Explore more exclusive insights at nextfin.ai.

Insights

Why did Kroger cut sales forecast?

How does IRA impact Kroger pharmacy?

What is Oracle cloud revenue growth?

Why did Oracle stock rally recently?

Is Oracle capex spending sustainable?

How does Kroger protect profit margins?

What is Oracle 2027 revenue guide?

Why is Kroger same-store sales weak?

What was Oracle quarterly capex spend?

What drives Oracle AI cloud demand?

Is Kroger dividend hike significant?

How does pharmacy drag affect Kroger?

What is Oracle backlog value now?

Why did Oracle shares drop premarket?

How does Kroger fund stock buybacks?

What risks face Oracle AI buildout?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App